PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7043175-2	1982	Compared to placebo conditions, clopamide monotherapy significantly increased serum low-density lipoprotein cholesterol (LDL-C) by 13% (p less than 0.025).	Clopamide	32-41	component of oligomeric golgi complex 2	Homo sapiens	84-119	
6137325-6	1983	Increases in LDL-C caused by chlorthalidone monotherapy were prevented or reversed by the addition of a beta-blocker, usually propranolol or atenolol (n = 18); increases in LDL-C during clopamide monotherapy were reversed after the addition of the beta-blocker pindolol (10 mg/day, n = 17).	Clopamide	186-195	component of oligomeric golgi complex 2	Homo sapiens	173-178	
7043175-2	1982	Compared to placebo conditions, clopamide monotherapy significantly increased serum low-density lipoprotein cholesterol (LDL-C) by 13% (p less than 0.025).	Clopamide	32-41	component of oligomeric golgi complex 2	Homo sapiens	121-126	
7043175-6	1982	These findings suggest that antihypertensive combination treatment with low doses of clopamide and pindolol is not only effective and well tolerated, but may also avoid the increase in serum LDL-C levels occurring when the thiazide-like diuretic is given alone.	Clopamide	85-94	component of oligomeric golgi complex 2	Homo sapiens	191-196